Literature DB >> 19811087

Correlation of circulating TLR2/4 expression with CD3+/4+/8+ T cells and Treg cells in HBV-related liver cirrhosis.

Jian-Qi Lian1, Xiao-Qin Wang, Ye Zhang, Chang-Xing Huang, Xue-Fan Bai.   

Abstract

Toll-like receptors (TLRs) 2 and 4 play a key role in chronic hepatitis B virus (HBV) infection. However, the role of TLRs in the pathogenesis of HBV-related liver cirrhosis and their regulation of the innate immune response of patients with liver cirrhosis remain unknown. To assess the contribution of TLR2/4 in HBV-related liver cirrhosis, we examined the expression of circulating TLR2 and TLR4 on peripheral blood mononuclear cells (PBMCs), CD4(+)CD25(+)CD127(low/-) Treg proportions, and CD3(+)/CD4(+)/CD8(+) T-cell counts in 30 liver cirrhosis patients, 21 chronic hepatitis B (CHB) patients, and 16 normal controls (NC). Furthermore, we analyzed the relationship between TLR2/4 expression and Treg proportions and T-cell counts. We show that the expression of TLR2 and TLR4 was significantly upregulated in patients with liver cirrhosis compared to NC. TLR4 expression was significantly increased in patients with liver cirrhosis compared to patients with CHB, and for TLR2 expression there were no differences between them. TLR4 expression showed a significant positive correlation with the frequency of Tregs in liver cirrhosis patients. TLR2 expression negatively correlated with CD3(+)/CD4(+)/CD8(+) T-cell counts and HBV viral load in patients with liver cirrhosis. These findings indicate that TLR may be involved in the pathogenesis of HBV-related liver cirrhosis, and may interact with Tregs and CD3(+)/CD4(+)/CD8(+) T cells in the immune response during HBV-related liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811087     DOI: 10.1089/vim.2009.0039

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  7 in total

1.  Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.

Authors:  Xue-Ping Nan; Ye Zhang; Hai-Tao Yu; Rui-Lin Sun; Mei-Juan Peng; Yu Li; Wen-Jing Su; Jian-Qi Lian; Jiu-Ping Wang; Xue-Fan Bai
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

2.  Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B.

Authors:  Erdem Akbal; Erdem Koçak; Seyfettin Köklü; Bilal Ergül; Ömer Akyürek; Fatma Meriç Yılmaz
Journal:  Viral Immunol       Date:  2017-04-17       Impact factor: 2.257

3.  Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells.

Authors:  Ying-Ju Li; Ping Zhu; Yu Liang; Wei-Guo Yin; Jian-Hua Xiao
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

4.  Toll-like receptors signaling contributes to immunopathogenesis of HBV infection.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Gastroenterol Res Pract       Date:  2011-11-29       Impact factor: 2.260

5.  Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.

Authors:  Ling Yang; Ekihiro Seki
Journal:  Front Physiol       Date:  2012-05-22       Impact factor: 4.566

6.  Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure.

Authors:  Xiufeng Wang; Yunqing Zhong; Rongzhen Zhang; Yueqiao Chen; Minggang Wang; Chao Lv; Dewen Mao
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-30       Impact factor: 2.629

7.  The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation.

Authors:  Malihe Moradzadeh; Sirous Tayebi; Hossein Poustchi; Kourosh Sayehmiri; Parisa Shahnazari; Elnaz Naderi; Ghodratollah Montazeri; Ashraf Mohamadkhani
Journal:  Adv Virol       Date:  2013-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.